U.S. Pharmacist Weekly News

March 20, 2024

ADHD Pharmacotherapy Reduces Mortality, Especially Unnatural Causes

Pharmacists are aware of the concerns that stimulants used to treat attention-deficit/hyperactivity disorder (ADHD) can cause cardiovascular issues and that some formulations of drugs to treat the condition are in short supply now. But, despite all of that, a new study finds pharmacotherapy for ADHD significantly lowers patient mortality, especially from unnatural causes. Read more.

Effects of Long-Term Supplement Use in Older Women

Physicians commonly recommend that their postmenopausal patients start supplementing with calcium and vitamin D, according to a study published in Annals of Internal Medicine. But what is the long-term effect of using the products? Find out how researchers determined a decrease in cancer risk but an increase in cardiovascular issues.

Melatonin Containers Blamed for Pediatric ED Visits

The use of melatonin products has exploded in the last few decades, and increasingly, products for children are flavored. One unintended result is a dramatic increase in emergency department (ED) visits for infants and young children with unsupervised medication ingestions. Find out why the CDC is suggesting more secure packaging as a solution in its Morbidity & Mortality Weekly Report.

For Neonatal Seizures

Now available for hospital formulary. Contact us to get the only FDA-approved treatment for neonatal seizures. Benzyl alcohol & preservative free. Read more.